Guardant Health GH
$ 32.76
5.75%
Quarterly report 2024-Q3
added 11-06-2024
Guardant Health Balance Sheet 2011-2024 | GH
Annual Balance Sheet Guardant Health
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
34.4 M | 1.02 B | 655 M | -20.1 M | -103 M | -140 M | -71.6 M | -16.6 M | - | - | - | - | - |
Long Term Debt |
1.14 B | 1.14 B | 1.13 B | 806 M | - | - | - | 16.5 M | - | - | - | - | - |
Long Term Debt Current |
28 M | 21.9 M | 12.9 M | 6.63 M | 7.14 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 91.4 M | 57.3 M | 14.7 M | 22.6 M | - | - | - | - | - |
Total Current Liabilities |
206 M | 193 M | 195 M | 66.8 M | 72.7 M | 46.9 M | - | - | - | - | - | - | - |
Total Liabilities |
1.63 B | 1.55 B | 1.56 B | 973 M | 164 M | 104 M | 34.3 M | 36.9 M | - | - | - | - | - |
Deferred Revenue |
18 M | 17.4 M | 11.3 M | 8.55 M | 12.3 M | 16.1 M | 3.11 M | 1.9 M | - | - | - | - | - |
Retained Earnings |
-2.14 B | -1.66 B | -1.01 B | -607 M | -353 M | -281 M | -196 M | -108 M | - | - | - | - | - |
Total Assets |
1.79 B | 1.61 B | 2.2 B | 2.27 B | 963 M | 587 M | 343 M | 117 M | - | - | - | - | - |
Cash and Cash Equivalents |
1.13 B | 142 M | 492 M | 833 M | 143 M | 141 M | 72.6 M | 33.6 M | - | - | - | - | - |
Book Value |
159 M | 60.2 M | 645 M | 1.3 B | 798 M | 483 M | 309 M | 79.7 M | - | - | - | - | - |
Total Shareholders Equity |
159 M | 60.2 M | 645 M | 1.3 B | 798 M | 483 M | 309 M | 79.7 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Guardant Health
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.14 B | 1.14 B | 1.14 B | 1.14 B | 1.14 B | 1.14 B | 1.14 B | 1.14 B | 1.14 B | - | 1.14 B | 1.13 B | 1.13 B | 1.13 B | 1.13 B | 806 M | 806 M | 806 M | 806 M | - | 33.3 M | 33.3 M | 33.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.6 B | 1.61 B | 1.64 B | 1.63 B | 1.57 B | 1.55 B | 1.56 B | 1.55 B | 1.54 B | - | 1.6 B | 1.56 B | 1.46 B | 1.44 B | 1.44 B | 916 M | 916 M | 916 M | 916 M | 115 M | 115 M | 115 M | 115 M | 62.5 M | 62.5 M | 62.5 M | 62.5 M | 34.3 M | 34.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
29.6 M | 29.4 M | 22.6 M | 18 M | 21.5 M | 12.2 M | 13.6 M | 17.4 M | 13.4 M | - | 10.6 M | 11.3 M | 7.32 M | 8.48 M | 8.36 M | 8.55 M | 7.34 M | 8.55 M | 11.9 M | 12.3 M | 13.1 M | 16.5 M | 12.3 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 3.11 M | 3.11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.47 B | -2.36 B | -2.26 B | -2.14 B | -1.95 B | -1.87 B | -1.8 B | -1.66 B | -1.52 B | - | -1.13 B | -1.01 B | -917 M | -809 M | -712 M | -607 M | -607 M | -607 M | -607 M | -353 M | -353 M | -353 M | -353 M | -281 M | -281 M | -281 M | -281 M | -196 M | -196 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
1.54 B | 1.61 B | 1.7 B | 1.79 B | 1.8 B | 1.84 B | 1.51 B | 1.61 B | 1.7 B | - | 2.13 B | 2.2 B | 2.23 B | 2.29 B | 2.35 B | 2.27 B | 2.27 B | 2.27 B | 2.27 B | 963 M | 963 M | 963 M | 963 M | 587 M | 587 M | 587 M | 587 M | 343 M | 343 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
585 M | 934 M | 1.03 B | 1.13 B | 457 M | 271 M | 224 M | 142 M | 158 M | 215 M | 574 M | 492 M | 832 M | 939 M | 869 M | 833 M | 833 M | 833 M | 833 M | 143 M | 143 M | 143 M | 143 M | 141 M | 141 M | 141 M | 141 M | 72.3 M | 72.3 M | - | - | 33.6 M | - | - | - | 4.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-60.1 M | -1.61 M | 68.3 M | 159 M | 228 M | 293 M | -44.6 M | 60.2 M | 167 M | - | 533 M | 645 M | 769 M | 847 M | 906 M | 1.36 B | 1.36 B | 1.36 B | 1.36 B | 848 M | 848 M | 848 M | 848 M | 525 M | 525 M | 525 M | 525 M | 309 M | 309 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-60.1 M | -1.61 M | 68.3 M | 159 M | 228 M | 293 M | -44.6 M | 60.2 M | 167 M | 319 M | 533 M | 645 M | 709 M | 788 M | 847 M | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 798 M | 798 M | 798 M | 798 M | 483 M | 483 M | 483 M | 483 M | 309 M | 309 M | - | - | 79.7 M | - | - | - | 83.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency